Trade Kura Oncology Inc - KURA CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.11 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023457% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001235% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 50.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 7.08 |
| Open | 7.1 |
| 1-Year Change | -65.16% |
| Day's Range | 6.96 - 7.2 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Mar 26, 2025 | 7.08 | 0.08 | 1.14% | 7.00 | 7.21 | 6.99 |
| Mar 25, 2025 | 7.07 | -0.41 | -5.48% | 7.48 | 7.60 | 7.03 |
| Mar 24, 2025 | 7.59 | -0.13 | -1.68% | 7.72 | 7.81 | 7.41 |
| Mar 21, 2025 | 7.78 | 0.23 | 3.05% | 7.55 | 7.98 | 7.51 |
| Mar 20, 2025 | 7.80 | 0.74 | 10.48% | 7.06 | 7.81 | 7.06 |
| Mar 19, 2025 | 7.21 | 0.09 | 1.26% | 7.12 | 7.31 | 7.03 |
| Mar 18, 2025 | 7.28 | 0.20 | 2.82% | 7.08 | 7.36 | 6.90 |
| Mar 17, 2025 | 7.23 | 0.12 | 1.69% | 7.11 | 7.29 | 6.91 |
| Mar 14, 2025 | 7.10 | -0.20 | -2.74% | 7.30 | 7.38 | 6.98 |
| Mar 13, 2025 | 7.23 | -0.28 | -3.73% | 7.51 | 7.87 | 7.23 |
| Mar 12, 2025 | 7.65 | 0.40 | 5.52% | 7.25 | 7.72 | 7.22 |
| Mar 11, 2025 | 7.28 | 0.12 | 1.68% | 7.16 | 7.34 | 6.73 |
| Mar 10, 2025 | 7.18 | -0.12 | -1.64% | 7.30 | 7.51 | 7.16 |
| Mar 7, 2025 | 7.48 | 0.09 | 1.22% | 7.39 | 7.69 | 7.39 |
| Mar 6, 2025 | 7.65 | 0.58 | 8.20% | 7.07 | 7.66 | 7.06 |
| Mar 5, 2025 | 7.31 | 0.00 | 0.00% | 7.31 | 7.49 | 7.24 |
| Mar 4, 2025 | 7.28 | 0.18 | 2.54% | 7.10 | 7.37 | 7.08 |
| Mar 3, 2025 | 7.20 | -0.30 | -4.00% | 7.50 | 7.79 | 7.16 |
| Feb 28, 2025 | 7.66 | 0.12 | 1.59% | 7.54 | 7.66 | 7.28 |
| Feb 27, 2025 | 7.60 | -0.18 | -2.31% | 7.78 | 7.93 | 7.55 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 20
- 100
- 500
- 1000
- 10000
Kura Oncology Inc Company profile
About Kura Oncology Inc
Kura Oncology, Inc. is a clinical-stage biopharmaceutical company. The Company’s segment is engaged in discovery and development of medicines for the treatment of cancer. Its pipeline consists of small molecule product candidates that target cancer signaling pathways. It is developing its lead product candidate, tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and hematologic indications. It is developing KO-539, a small molecule inhibitor of the Lysine K-specific Methyltransferase 2A (KMT2A) interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Kura Oncology Inc revenues was not reported. Net loss increased 46% to $130.5M. Higher net loss reflects General and administrative - Balancing increase of 35% to $30.4M (expense), Stock-based Compensation in SGA increase of 82% to $16.1M (expense), Share-based compensation increase of 88% to $7.5M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$1.69 to -$1.97.
| Industry: | Bio Therapeutic Drugs |
12730 High Bluff Drive, Suite 400
SAN DIEGO
CALIFORNIA 92130
US
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com